Does active psychosis cause neurobiological pathology? A critical review of the neurotoxicity hypothesis

Psychological Medicine

Volumn 44, Issue 8, 2014, Pages 1577-1590

  Rund, B R ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Key words Duration of untreated psychosis (DUP); morphology; neurocognition; neurotoxicity; review; schizophrenia

Indexed keywords

BRAIN DISEASES; COGNITION DISORDERS; COMPLICATION; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOSIS;

BRAIN DISEASES; COGNITION DISORDERS; HUMANS; PSYCHOTIC DISORDERS;

EID: 84899748448     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291713002341     Document Type: Review

References (47)

1. Addington J, Van Mastrigt S, Addington D (2004). Duration of untreated psychosis: impact on 2-year outcome. Psychological Medicine 34, 277-284.
2. Amminger GP, Edwards J, Brewer WJ, Harrigan S, McGorry PD (2002). Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia. Schizophrenia Research 54, 223-230.
3. Ayres AM, Busatto GF, Menezes PR, Schaufelberger MS, Coutinho L, Murray RM, McGuire PK, Rushe T, Scazufca M (2007). Cognitive deficits in first-episode psychosis: a population-based study in Sáo Paulo, Brazil. Schizophrenia Research 90, 338-343.
4. Bangalore SS, Goradia DD, Nutche J, Diwadkar VA, Prasad KMR, Keshavan MS (2009). Untreated illness duration correlates with gray matter loss in first-episode psychoses. Neuroreport 20, 729-734.
5. Barnes TRE, Hutton SB, Chapman MJ, Mutsatsa S, Puri BK, Joyce EM (2000). Clinical correlates of duration of untreated psychosis. British Journal of Psychiatry 177, 207-211.
6. Becker HE, Nieman DH, Wilting S, Dingemans PM, van de Fliert JR, Velthorst E, de Haan L, van Amelsvoort TA, Linszen DH (2010). Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration? Psychological Medicine 40, 1599-1606.
7. Cahn W, Pol HEH, Lems EBTE, van Haren NEM, Schnack HG, van der Linden JA, Schothorst P, van Engeland H, Kahn RS (2002). Brain volume changes in first-episode schizophrenia. Archives of General Psychiatry 59, 1002-1010.
8. Chang WC, Hui CLM, Tang JYM, Wong GHY, Chan SKW, Lee EHM, Chen EYH (2013). Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia: a 3-year prospective follow-up study. Psychological Medicine 43, 1883-1893.
9. Craig TJ, Bromet EJ, Fennig S, Tanenberg-Karant M, Lavelle J, Galambos N (2000). Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series? American Journal of Psychiatry 157, 60-66.
10. Crespo-Facorro B, Roiz-Santiáñez R, Pelayo-Terán JM, Gonzalez-Blanch C, Perez-Iglesias R, Gutierrez A, de Lucas EM, Tordesillas D, Vázguez-Barquero JL (2007). Caudate nucleus volume and its clinical and cognitive correlations in first episode schizophrenia. Schizophrenia Research 91, 87-96.
11. Cuesta MJ, de Jalòn EG, Campos MS, Ibanez B, Sanchez-Torres AM, Peralta V (2012). Duration of untreated negative and positive symptoms of psychosis and cognitive impairment in first-episode psychosis. Schizophrenia Research 141, 222-227.
12. Fannon D, Chitnis X, Doku V, Tennakoon L, O'Ceallaigh S, Soni W, Sumich A, Lowe J, Santamaria M, Sharma T (2000). Features of structural brain abnormality detected in first-episode psychosis. American Journal of Psychiatry 157, 1829-1834.
13. Galderisi S, Davidson M, Kahn RS, Mucci A, Boter H, Gheorghe MD, Rybakowski JK, Libiger J, Dollfus S, López-Ibor JJ, Peuskens J, Hranov LG, Fleischhacker WW (2009). Correlates of cognitive impairment in first-episode schizophrenia: the EUFEST study. Schizophrenia Research 115, 104-114.
14. Galinska B, Szulc A, Czernikiewicz A (2005). Duration of untreated psychosis in first-episode schizophrenia: clinical and cognitive correlates [in Polish]. Psychiatria Polska 39, 859-868.
15. Gaynor K, Dooley B, Lawlor E, Lawoyin LR, O'Callaghan E (2009). Cognitive deterioration and duration of untreated psychosis. Early Intervention in Psychiatry 3, 157-160.
16. Goldberg TE, Burdick KE, McCormack J, Napolitano B, Patel RC, Sevy SM, Goldman R, Lencz T, Malhotra AK, Kane JM, Robinson DG (2009). Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first-episode schizophrenia. Schizophrenia Research 107, 262-266.
17. Hawkins KA, Keefe RSE, Christensen BK, Addington J, Woods SW, Callahan J, Zipursky RB, Perkins DO, Tohen M, Breier A, McGlashan TH (2008). Neuropsychological course in the prodrome and first episode of psychosis: findings from the PRIME North America Double Blind Treatment Study. Schizophrenia Research 105, 1
18. Heydebrand G, Weiser M, Rabinowitz J, Hoff AL, DeLisi LE, Csernansky JG (2004). Correlates of cognitive deficits in first-episode schizophrenia. Schizophrenia Research 68, 1-9.
19. Hietala J, Cannon TD, Sylvalathi E, Vilkman H, Laakso A, Vahlberg T, Alakare B, Räkköläinen V, Salokangas RKR (2003). Regional brain morphology and duration of illness in never-medicated first-episode patients with schizophrenia. Schizophrenia Research 64, 79-81.
20. Ho B-C, Alicata D, Ward J, Moser DJ, O'Leary DS, Arndt S, Andreasen NC (2003). Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. American Journal of Psychiatry 160, 142-148.
21. Hoff AL, Sakuma M, Razi K, Heydebrand G, Csernansky JG, DeLisi LE (2000). Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia. American Journal of Psychiatry 157, 1824-1828.
22. Joyce E, Hutton S, Mutsatsa S, Gibbins H, Webb E, Paul S, Robbins T, Barnes T (2002). Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study. British Journal of Psychiatry 181, 38-44.
23. Keshavan MS, Haas GL, Kahn CE, Aguilar E, Dick EL, Schooler NR, Sweeney JA, Pettegrew JW (1998). Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible? Journal of Psychiatric Research 32, 161-167.
24. Lappin JM, Morgan K, Morgan C, Hutchinson G, Chitnis X, Suckling J, Fearon P, McGuire PK, Jones PB, Leff J, Murray RM, Dazzan P (2006). Gray matter abnormalities associated with duration of untreated psychosis. Schizophrenia Research 83, 145-153.
25. Lappin JM, Morgan KD, Morgan C, Dazzan P, Reichenberg A, Zanelli JW, Fearon P, Jones PB, Lloyd T, Tarrant J, Farrant A, Leff J, Murray RM (2007). Duration of untreated psychosis and neuropsychological function in first-episode psychosis. Schizophrenia Research 95, 103-110.
26. Lawoyin R, Gaynor K, Dooley B, Lawelor E, Clarke M, O'Callaghan E (2007). Toxic psychosis? Duration of untreated psychosis, symptomatology and cognitive deterioration in first episode psychosis. Irish Journal of Psychological Medicine 24, 145-148.
27. Leeson VC, Barnes TRE, Harrison M, Matheson E, Harrison I, Mutsatsa SH, Ron MA, Joyce EM (2010). The relationship between IQ, memory, executive function, and processing speed in recent-onset psychosis: 1-year stability and clinical outcome. Schizophrenia Bulletin 36, 400-409.
28. Madsen AL, Karle A, Rubin P, Cortsen M, Andersen HS, Hemmingsen R (1999). Progressive atrophy of the frontal lobes in first-episode schizophrenia: interaction with clinical course and neuroleptic treatment. Acta Psychiatrica Scandinavica 100, 367-374.
29. Malla AK, Bodnar M, Joober R, Lepage M (2011). Duration of untreated psychosis is associated with orbital-frontal grey matter volume reductions in first-episode psychosis. Schizophrenia Research 125, 13-20.
30. Malla AK, Mittal C, Lee M, Scholten DJ, Assis L, Norman RMG (2002). Computed tomography of the brain morphology of patients with first-episode schizophrenic psychosis. Journal of Psychiatry and Neuroscience 27, 350-358.
31. Marshall M, Rathbone J (2011). Early intervention for psychosis. Cochrane Database of Systematic Reviews. Issue 6, Art No. CD004718.
32. McGlashan TH (2006). Is active psychosis neurotoxic? Schizophrenia Bulletin 32, 609-613.
33. Norman RMG, Townsend L, Malla AK (2001). Duration of untreated psychosis and cognitive functioning in first-episode patients. British Journal of Psychiatry 179, 340-345.
34. Olabi B, Ellison-Wright I, McIntosh AM, Wood SJ, Bullmore E, Lawrie SM (2011). Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biological Psychiatry 70, 88-96.
35. Penttilä M, Jääskeläinen E, Haapea M, Tanskanen P, Veijola J, Ridler K, Murray GK, Barnes A, Jones PB, Isohanni M, Koponen H, Miettunen J (2010). Association between duration of untreated psychosis and brain morphology in schizophrenia within the Northern Finland 1966 Birth Cohort. Schizophrenia Research 123, 145-152.
36. Rapp C, Studerus E, Bugra H, Aston J, Tamagni C,Walter A, Pflueger M, Borgwardt S, Riecher-Rössler A (2013). Duration of untreated psychosis and cognitive functioning. Schizophrenia Research 145, 443-449.
37. Rund BR (2009). Is schizophrenia a neurodegenerative disorder? Nordic Journal of Psychiatry 63, 196-201.
38. Rund BR, Melle I, Friis S, Johannessen JO, Larsen TK, Midbøe LJ, Opjordsmoen S, Simonsen E, Vaglum P, McGlashan T (2007). The course of neurocognitive functioning in first-episode psychosis and its relation to premorbid adjustment, duration of untreated psychosis, and relapse. Schizophrenia Research 91, 132-140.
39. Rund BR, Melle I, Friis S, Larsen TK, Midbøe LJ, Opjordsmoen S, Simonsen E, Vaglum P, McGlashan T (2004). Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. American Journal of Psychiatry 161, 466-472.
40. Scully PJ, Coakley G, Kinsella A, Waddington JL (1997). Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia. Psychological Medicine 27, 1303-1310.
41. Sheitman BB, Lieberman JA (1998). The natural history and pathophysiology of treatment resistant schizophrenia. Journal of Psychiatric Research 32, 143-150.
42. Takahashi T, Suzuki M, Tanino R, Zhou S-Y, Hagino H, Niu L, Kawasaki Y, Seto H, Kurachi M (2007). Volume reduction of the left planum temporale gray matter associated with long duration of untreated psychosis in schizophrenia: a preliminary report. Psychiatry Research 154, 209-219.
43. Townsend LA, Norman RMG, Malla AK, Rychlo AD, Ahmed RR (2002). Changes in cognitive functioning following comprehensive treatment for first-episode patients with schizophrenia spectrum disorders. Psychiatry Research 113, 69-81.
44. Wood SJ, Pantelis C, Yung AR, Velakoulis D, McGorry PD (2009). Brain changes during the onset of schizophrenia: implications for neurodevelopmental theories. Medical Journal of Australia 190, 10-13.
45. Wyatt RJ (1991). Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin 17, 325-351.
46. Zhou F-C, Xiang Y-T, Wang C-Y, Dickerson F, Au RWC, Zhou J-J, Zhou Y, Shum DHK, Chiu HFK, Man D, Lee EHM, Yu X, Chan RCK, Ungvari GS (2012). Characteristics and clinical correlates of prospective memory performance in first-episode schizophrenia. Schizophrenia Research 135, 34-39.
47. Ziermans TB, Schothorst PF, Schnack HG, Koolschijn CMP, Kahn RS, van Engeland H, Durston S (2010). Progressive structural brain changes during development of psychosis. Schizophrenia Bulletin 38, 519-530.